Peter Below

927 total citations
11 papers, 705 citations indexed

About

Peter Below is a scholar working on Molecular Biology, Organic Chemistry and Rheumatology. According to data from OpenAlex, Peter Below has authored 11 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Rheumatology. Recurrent topics in Peter Below's work include Glycogen Storage Diseases and Myoclonus (5 papers), Synthetic Organic Chemistry Methods (3 papers) and Enzyme function and inhibition (2 papers). Peter Below is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (5 papers), Synthetic Organic Chemistry Methods (3 papers) and Enzyme function and inhibition (2 papers). Peter Below collaborates with scholars based in Germany, United States and Austria. Peter Below's co-authors include Horst Hemmerle, Andreas W. Herling, Gerrit Alexander Schubert, Hans-Joerg Burger, Peter W. Schindler, William J. Arion, Wesley K. Canfield, Wolfgang Kreiser, Dietmar Schwab and Heinz‐Werner Kleemann and has published in prestigious journals such as Journal of Medicinal Chemistry, Archives of Biochemistry and Biophysics and Tetrahedron Letters.

In The Last Decade

Peter Below

11 papers receiving 648 citations

Peers

Peter Below

MB

PHARM

EDM

RHEUM

OC

Peter W. Schindler Germany

Hans-Joerg Burger United States

Morten A. Kall Denmark

Asma Ejaz Pakistan

Eunjung Son South Korea

Boobalan Raja India

Hideko Morishita Japan

Woon‐Gye Chung South Korea

Panchanatham Sachdanandam India

Ryoko Tsubouchi Japan

Peter W. Schindler Germany

Peter Below

226 ×1.0

MB

195 ×1.0

PHARM

105 ×0.8

EDM

78 ×0.7

RHEUM

65 ×0.7

OC

Citations per year, relative to Peter Below Peter Below (= 1×) peers Peter W. Schindler

Countries citing papers authored by Peter Below

Since Specialization

Citations

This map shows the geographic impact of Peter Below's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Below with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Below more than expected).

Fields of papers citing papers by Peter Below

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Below. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Below. The network helps show where Peter Below may publish in the future.

Co-authorship network of co-authors of Peter Below

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Below. A scholar is included among the top collaborators of Peter Below based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Below. Peter Below is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Peukert, Stefan, Joachim Brendel, Bernard Pirard, et al.. (2003). Identification, Synthesis, and Activity of Novel Blockers of the Voltage-Gated Potassium Channel Kv1.5. Journal of Medicinal Chemistry. 46(4). 486–498. 45 indexed citations

2.

Arion, William J., Wesley K. Canfield, Hans-Joerg Burger, et al.. (1998). Chlorogenic Acid Analogue S 3483: A Potent Competitive Inhibitor of the Hepatic and Renal Glucose-6-Phosphatase Systems. Archives of Biochemistry and Biophysics. 351(2). 279–285. 60 indexed citations

3.

Herling, Andreas W., et al.. (1998). Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system. American Journal of Physiology-Gastrointestinal and Liver Physiology. 274(6). G1087–G1093. 67 indexed citations

4.

Schindler, Peter W., Peter Below, Horst Hemmerle, et al.. (1998). Identification of two new inhibitors of the hepatic glucose-6-phosphatase system. Drug Development Research. 44(1). 34–40. 14 indexed citations

5.

Arion, William J., Wesley K. Canfield, Peter W. Schindler, et al.. (1997). Chlorogenic Acid and Hydroxynitrobenzaldehyde: New Inhibitors of Hepatic Glucose 6-Phosphatase. Archives of Biochemistry and Biophysics. 339(2). 315–322. 214 indexed citations

6.

Hemmerle, Horst, Hans-Joerg Burger, Peter Below, et al.. (1997). Chlorogenic Acid and Synthetic Chlorogenic Acid Derivatives: Novel Inhibitors of Hepatic Glucose-6-phosphate Translocase. Journal of Medicinal Chemistry. 40(2). 137–145. 252 indexed citations

7.

Hemmerle, Horst, Hans-Jörg Burger, Peter Below, et al.. (1997). ChemInform Abstract: Chlorogenic Acid and Synthetic Chlorogenic Acid Derivatives: Novel Inhibitors of Hepatic Glucose‐6‐phosphate Translocase.. ChemInform. 28(18). 4 indexed citations

8.

Baader, E., Wilhelm Bartmann, G. Beck, et al.. (1989). Enantioselective synthesis of a new fluoro-substituted HMG-COA reductase inhibitor. Tetrahedron Letters. 30(38). 5115–5118. 19 indexed citations

9.

Kreiser, Wolfgang & Peter Below. (1985). Erste Synthese von (+)‐Homofenchon (1,4,4‐Trimethylbicyclo[3.2.1]octan‐3‐on). Liebigs Annalen der Chemie. 1985(1). 203–209. 11 indexed citations

10.

Kreiser, Wolfgang, Peter Below, & Ludger Ernst. (1985). Erste Synthese von rac‐Homofenchon (1,4,4‐Trimethylbicyclo‐[3.2.1]octan‐3‐on). Liebigs Annalen der Chemie. 1985(1). 194–202. 6 indexed citations

11.

Kreiser, Wolfgang & Peter Below. (1981). Zur regioselektivität beim aldol-ringschluss. Tetrahedron Letters. 22(5). 429–432. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact